YC W22
Torpedo Therapeutics
High-precision, closed-loop neuromodulation devices
About
We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.
Founder
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Torpedo Therapeutics.
See family office activityIndustry & Focus
HealthcareMedical DevicesNeurotechnologyBiotech